Analyst ratings are aggregated from multiple third-party sources and may be inaccurate, incomplete, or outdated. All ratings remain the sole responsibility of their original providers. Rankings are based on the 3-year performance of a simulated $100,000 account trading on analyst ratings data.
| Trades 2519 | Longs Won 1241/2462 50% | Profit Factor 0.78 |
| Profitability | Shorts Won 16/57 28% | Standard Deviation $1,361.17 |
| Average Win $167.8 | Best Trade (Mar 18) $50,177.94 | Sharpe Ratio -283.14 |
| Average Loss -$215.4 | Worst Trade (Dec 27) -$26,159.42 | Z-Score -16.5 (100%) |
| Commissions $0 | Avg. Trade Length 1m 4w 1d | Expectancy -$23.92 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | - | - | - | - | - | - | - | - | - | - |
| Consecutive Losing Trades | 186 | 168 | 149 | 130 | 112 | 93 | 74 | 56 | 37 | 19 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPG Ascentage Pharma Group International ADR | 1,318.41 | $19,578.42 | $19,564.05 | - | -$14.37 | -0.07% | -0.073% |
ZBIO Zenas BioPharma, Inc. | 787.55 | $21,240.14 | $20,170.89 | - | -$1,069.25 | -5.03% | +3.026% |